Amylin family peptides and methods for making and using them

Details for Australian Patent Application No. 2010212468 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Soares, Christopher J.; Hanley, Michael R.; Lewis, Diana Yvonne; Parkes, David Geoffrey; Jodka, Carolyn Marie; Prickett, Kathryn S.; Ghosh, Soumitra; Mack, Christine Marie; Lin, Qing

Agent Freehills

Pub. Number AU-A-2010212468

Parent 2005320351

Filing date 20 August 2010

Wipo publication date 9 September 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

9 September 2010 Application Open to Public Inspection

  Published as AU-A-2010212468

9 September 2010 Complete Application Filed

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application was refused. Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212469-Bioreactor for continuous production of bioleaching solutions for inoculation and irrigation of sulfide-ore bioleaching heaps and dumps

2010212467-4-(2-fluorophenyl)-6-methyl-2-(1-pipera zinyl)thieno(2,3-D) pyrimidine in the treatment of functional bowel disorder